Tahir Mahmood, PhD

Chief Executive Officer

Tahir co-founded AMT, where he has overseen the company’s growth from concept to clinical trials in patients through multiple equity financing rounds. He was closely involved in the early development of the technology and also led the company’s partnering and corporate development activities. | READ MORE

Liz Bhatt

Chief Business and Strategy Officer

Liz joined AMT to lead multiple business functions, including Corporate Development and Strategy, Alliance Management, Portfolio Strategy and Project Management, and Commercial Development.  Liz brings more than twenty-five years of biotech and pharmaceutical company experience, including roles in corporate development, corporate strategy, and commercial strategy.  | READ MORE

Shawn Cross

Chief Financial Officer

Shawn joined AMT as chief financial officer in 2020 where he leads the company’s finance strategy and oversees financial operations. He brings over 20 years of biopharmaceutical strategic advisory and capital market experience. Prior to joining AMT, Mr. Cross was at JMP Securities where he served as managing director and co-head of healthcare investment banking. | READ MORE

Brandon Hants

Vice President, Finance and Business Operations

Brandon has twenty years of biotechnology experience in various disciplines from both large and small companies. He has held roles in Financial Planning & Analysis, Accounting, Financial Systems, Treasury, Operations Finance, Supply Chain and Manufacturing. | READ MORE

Bittoo Kanwar, MD

Chief Medical Officer

Bittoo leads Clinical Development activities at Applied Molecular Transport, where he is overseeing the current clinical program AMT-101 and developing clinical strategy for the company’s pipeline assets and technology platforms. | READ MORE

Derek Maclean, PhD

Vice-President, Pharmaceutical Sciences

Derek is a pharmaceutical scientist with over 20 years of operational and management experience in medicinal chemistry, formulation development, and product manufacturing. Prior to joining Applied Molecular Transport, Derek was Vice-President of Chemistry Research at Relypsa Inc, leading the chemical development of advanced polymer therapeutics. | READ MORE

Randall Mrsny, PhD

Chief Scientific Officer

An epithelial biologist, Randy has more than three decades of industry and academic experience in pharmaceutical sciences and research into the mucosal trafficking of peptide and protein therapeutics.  | READ MORE

Chuck Olson

Senior Vice President, Operations

Chuck is a biotechnology industry professional with broad scientific and operational experience, having a focus in process development, manufacturing and other CMC related activities.  With over thirty years of experience, he has enabled the production of virtually every class and size of biological product from recombinant proteins, enzymes, blood products, natural products, adenovirus and whole cell immunotherapy. | READ MORE

Andy Whitney, PhD

Vice President, Head of Preclinical Development and Translational Science

Andy leads AMT’s preclinical biology and translational activities.  A cell biologist by training, Andy brings over 20 years of experience in drug discovery and development in autoimmune/inflammatory, oncology and rare diseases. Andy was most recently VP, Biology at BridgeBio and some of its subsidiary companies. | READ MORE